References
- Hall WD, Ross JE, Lynskey MT, Law MG, Degenhardt LJ. How many dependent heroin users are there in Australia? Med J Aust 2000;173:528–31.
- Brewer C. Ultra-rapid, antagonist-precipitated opiate de- toxification under general anaesthesia or sedation. Addict Biol 1997;2:291–302.
- Walsh SL, June HL, Schuh KJ, Preston KL, Bigelow GE, Stitzer ML. Effects of buprenorphine and methadone in methadone-maintained subjects. Psychopharmacology 1995;119:268–76.
- Dietze P, Fitzgerald J. Interpreting changes in heroin supply in Melbourne: droughts, gluts or cycles? Drug Alcohol Rev 2002; 21:295–303.
- Merrill J, Marshall R. Opioid detoxification using naloxone. Drug Alcohol Rev 1997;16:3–6.
- Kleber HD. Ultrarapid opiate detoxification. Addiction 1998;93:1629–33.
- Amass L, Kamien JB, Mikulich SK. Efficacy of daily and alternate-day dosing regimens with the combination bupre- norphine-naloxone tablet. Drug Alcohol Depend 2000;58:143–52.
- Gowing L, Ali R, White J. Buprenorphine for the manage- ment of opioid withdrawal [Cochrane Review]. In: The Cochrane Library, Issue 3. Oxford: Update Software, 2002.
- Clark NC, Lintzeris N, Muhleisen PJ. Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose. Med J Aust 2002;176:167–8.
- Jacobs EA, Bickel WK. Precipitated withdrawal in an opioid-dependent outpatient receiving alternate-day bupre- norphine dosing. Addiction 1999;94:140–1.